Global Precision Medicine Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Precision Medicine market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.
According to MarkNtel Advisors’ research report titled “Global Precision Medicine Market Analysis, 2020”, the Global Precision Medicine market is anticipated to grow at a CAGR of around 11% during 2020-25F owing to the factors such as escalating investment by the major pharmaceutical companies in precision medicine, increasing burden of cancer cases, and booming ageing population worldwide. Moreover, technological advancement in wireless technologies and big data analytics, the rising patient inclination toward personalized treatment, and significant strides in the research areas pertaining to precision medicine in the recent years are some of the factors expected to fuel the growth of the market in the coming years. Moreocer, COVID-19 has a positive impact on the Global precison medicine market as it is widely use to accelerate the COVID-19 treatment.
Pharmaceutical Companies Are Expected to Attain Highest CAGR
Based on end user, pharmaceutical companies are expected to grow at a highest CAGR during 2020-25 in the Global Precision Medicine market on account of rising incidences of neurological disorders and increasing spending by the giant pharmaceutical companies in the research and development of precision medicine. Moreover, surging government initiatives to improve healthcare and reduction in the overall healthcare costs are projected to drive the growth of the Precision Medicine market globally in the near future as stated in the MarkNtel Advisors’ research report “Global Precision Medicine Market Analysis, 2020”.
According to MarkNtel Advisors, the key players with a considerable market share in the Global Precision Medicine market include Orion Health, 2B Precise, Fabric Genomics, Pfizer, Gene 42, IBM Watson Health, Philips Healthcare, Medtronic, Nanthealth, Navican, N-of-One, PierianDx, Sunquest Information System, Tempus, Novartis, Translational Software, Biocrates Life Sciences AG, anostring Technologies, Thermo Fisher Scientific, Quest Diagnostics Incorporated etc.
Key Questions Answered in the Market Research Report:
Market Outlook, Segmentation and Statistics
Frequently Asked Questions:
Q. What is the historical year, base year and forecast year considered in the research report on Global Precision Medicine Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.
Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Million.
Q. What would be the growth rate or CAGR of Global Precision Medicine Market during 2020-25?
A. The Global Precision Medicine Market is forecast to grow at a CAGR of 11% during 2020-25.
Q. Who are the key competitors or players operating in Global Precision Medicine Market?
A. Orion Health, 2B Precise, Fabric Genomics, Pfizer, Gene 42, IBM Watson Health, Philips Healthcare, Medtronic, Nanthealth, Navican, N-of-One, PierianDx, Sunquest Information System, Tempus, Novartis, Translational Software, Biocrates Life Sciences AG, anostring Technologies, Thermo Fisher Scientific, Quest Diagnostics Incorporated are few of the leading players in the Global Precision Medicine Market.
Q. Which application segment would emerge as an opportunity area for players in Global Precision Medicine Market?
A. Oncology is expected to attain the highest CAGR during the forecast period and maintain its significant market share.
Q. Which region would emerge as an opportunity area for players in Global Precision Medicine Market?
A. Asia-Pacific continue to grow at a highest CAGR, presenting immense opportunities for market players of Global Precision Medicine Market.